Status:
COMPLETED
Emails Promoting COVID-19 Vaccination Among Healthcare Workers
Lead Sponsor:
Geisinger Clinic
Conditions:
Vaccination Refusal
Communication
Eligibility:
All Genders
Phase:
NA
Brief Summary
In this evaluation, two versions of emails will be sent to Geisinger employees who have not been vaccinated against COVID-19. A delayed-contact control group will be emailed after a delay of at least ...
Detailed Description
The researchers aim to evaluate the effectiveness of email reminders in promoting COVID-19 vaccinations among Geisinger employees. The project will compare two emails, which will vary in the subject l...
Eligibility Criteria
Inclusion
- Employees at Geisinger Health System who have not gotten a COVID-19 vaccination
Exclusion
- None
Key Trial Info
Start Date :
January 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 20 2021
Estimated Enrollment :
9566 Patients enrolled
Trial Details
Trial ID
NCT04728594
Start Date
January 15 2021
End Date
January 20 2021
Last Update
July 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geisinger
Danville, Pennsylvania, United States, 17822